Overcoming Challenges in Congenital CMV Screening: Optimizing Laboratory Practices

Congenital Cytomegalovirus (cCMV) screening presents unique challenges for laboratories, particularly due to the relatively low incidence of the condition. This workshop will explore the complexities of newborn cCMV screening using nucleic acid amplification tests (NAAT). Participants will learn about quality management strategies to reduce false positives, including repeat testing. The workshop will also discuss the future of universal cCMV screening in the US, emphasizing the need for higher-throughput automated assays and cost-effective solutions. Join us to gain insights into optimizing cCMV screening protocols and overcoming the hurdles in making universal screening a reality.